Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 30, 2006

Articles

Favourites:
ADD

PET Imaging of Norepinephrine Transporters
pp. 3831-3845(15)
Authors: Ding, Yu-Shin; Lin, Kuo-Shyan; Logan, Jean

Favourites:
ADD
Favourites:
ADD

Sigma Receptor Ligands: Possible Application as Therapeutic Drugs and as Radiopharmaceuticals
pp. 3857-3876(20)
Authors: Hashimoto, Kenji; Ishiwata, Kiichi

Favourites:
ADD
Favourites:
ADD

Imaging of Muscarinic Receptors in the Central Nervous System
pp. 3901-3913(13)
Author: Eckelman, W. C.

Favourites:
ADD

Regulation of Female Fertility and Identification of Future Contraceptive Targets
pp. 3915-3928(14)
Authors: Chengalvala, Murty V.; Meade Jr., Edwin H.; Cottom, Joshua E.; Hoffman, William H.; Shanno, Linda K.; Wu, May M.; Kopf, Gregory S.; Shen, Emily S.

Favourites:
ADD

IgE, Allergic Diseases, and Omalizumab
pp. 3929-3944(16)
Author: DuBuske, L. M.

Favourites:
ADD

Lipid Lowering Therapy in the Elderly: Is there a Benefit?
pp. 3945-3960(16)
Authors: Kalantzi, Kallirroi J.; Milionis, Haralampos J.; Mikhailidis, Dimitri P.; Goudevenos, John A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content